Clinical trial · Observational
Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression
Evaluation of Serum Tumor Endothelial Marker 1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression
NCT05779553CI-TRIAL-00064904not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Aim of work 1. measurement level of serumTEM1 in CRC patients by ng/ml using ELISA kits . 2. find relation between serum TEM1 level and staging of CRC patients . 3. measurement of serum CEA , CA19-9 levels by ng/ml so we can can compare their levels with serum TEM1 level in CRC patients .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Group (1)(patient group):
- description
- who are 50 newly diagnosed patient with colorectal cancer, who will be admitted at South Egypt Cancer Inistitute and Assiut University Hospital during 2023. Patients group will be furtherly subclassified according to the American Joint Committee on Cancer Staging,TNM staging classification
- interventionNames
- Diagnostic Test: Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
- label
- Group (2) (control group)
- description
- 40 apparently healthy individuals with matched age and sex are included in this study as a control group for comparison.
- interventionNames
- Diagnostic Test: Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
Primary outcomes (1)
- measure
- Tumor endothelial marker 1 in colorectal cancer
- timeFrame
- baseline
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1-newly diagnosed CRC patients. Exclusion Criteria: 1. chemotherapy 2. radiotherapy 3. surgical treatment 4. heart failure 5. angina 6. liver cirrhosis 7. renal cell carcinoma 8. gastric cancer.
References
Publications (0)
Data not yet available
No reference posted for this study.